What does MSAFP stand for?

Maternal Serum Alpha-Fetoprotein

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Military and Security Applications of Evolutionary Computation (workshop) Mean-Squared Amplitude-Estimation Error Manx Sports Aid Foundation (est. 1991; Isle of Man Sports Council; Isle of Man, UK) Master of Science in Accounting and Financial Management McMaster Student Absence Form (McMaster University; Canada) Meconium Stained Amniotic Fluid Michigan Society of American Foresters Montana Society of American Foresters (est. 1900) Multimedia Services Affiliate Forum Maternal Serum Alpha Fetoprotein Screening (American Pregnancy Association)		Magnolia Springs Assembly of God (Hurley, MS) Master Street Address Guide Media Support Advisory Group Medical School Application Guide (book) Mt. San Antonio Gardens (Pomona and Claremont, CA Green House retirement project) Multifunction Self-Aligned Gate Multinational Small Arms and Ammunition Group Multiservice Access Gateway Municipal Street Address Guide Metairie Small Animal Hospital (Metairie, LA)

Samples in periodicals archive:

An interesting, but little-known fact is that 50% of accretas are associated with elevations of second trimester maternal serum alpha-fetoprotein (MSAFP) well above 2.

Recognizing Placenta Accreta Before Delivery

The test is sometimes abbreviated as MSAFP, standing for maternal serum alpha-fetoprotein.

Testing Alpha-Fetoprotein (AFP) in Blood

Eligibility criteria included screening for maternal serum alpha-fetoprotein (MSAFP) levels between 15 and 22 weeks of pregnancy, > 14 years of age, competency in English, singleton pregnancy with no known congenital or chromosomal anomalies at the time of recruitment, and no prepregnancy diabetes mellitus.

Maternal fish consumption, mercury levels, and risk of preterm ...

Biochemical Testing Maternal serum alpha-fetoprotein (MSAFP) testing was begun in the 1970s to screen for neural tube defects.

Non-invasive approach to prenatal diagnosis

Combination of elevated maternal serum alpha-fetoprotein (MSAFP) and low estriol is highly predictive of anencephaly.

Preventing and detecting neural tube defects

Biochemical Testing Maternal serum alpha-fetoprotein (MSAFP) testing was begun in the 1970s to screen for neural tube defects.

Special Feature: Non-Invasive Approach to Prenatal Diagnosis

Maternal serum alpha-fetoprotein (MS-AFP) screening for neural tube defects, trisomy 21 (Down's syndrome), and other gestational abnormalities has become increasingly common over the last few years (see Figures I and 11).

Operational considerations in maternal serum AFP screening

Most cases can be detected by midpregnancy with maternal serum alpha-fetoprotein screening and ultrasound.

Fetal Surgery for Myelomeningocele